PhoreMost Ltd and University of Cambridge collaborate
Identifying innovative drug targets for neurodegenerative disease
14-Oct-2016 -
PhoreMost Ltd (PhoreMost), a biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, has entered into a research collaboration with the laboratory of Professor David Rubinsztein at the University of Cambridge. The groups will study and translate essential cellular ...
autophagy
collaborations
drug discovery
+6